Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Efficacy of brigatinib in patients with ALK+ NSCLC in the phase 1/2 study. (A) Kaplan-Meier estimates of investigator-assessed PFS. Of the 79 patients with ALK+ NSCLC, 61 (77%) had an event. (B) OS. Of the 79 patients, 39 (49%) died. Tick marks in Kaplan-Maier plots indicate censored data. a180 mg once daily with 7-day lead-in at 90 mg. ALK+, ALK rearrangement positive; CI, confidence interval; NR, not reached; OS, overall survival; PFS, progression-free survival.
